Evaluation of the Coping Long Term With Active Suicide Program

Suicide Clinical Trial

— CLASP  

Official title:

Evaluation of the Coping Long Term With Active Suicide Program

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02313753
• Other study ID #: MH101129
• Status: Completed
• Phase: N/A
• Start date: December 2014
• Est. completion date: March 31, 2021

Study information

• Verified date: June 2021
• Source: Butler Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the utility of the Coping Long Term with Active Suicide Program (CLASP) for reducing suicidal behavior.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 224
• Est. completion date: March 31, 2021
• Est. primary completion date: March 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Current patient at Butler Hospital

2. Suicide attempt or suicidal ideation with intent to make a suicide attempt within 48 hours of hospitalization as indicated on the hospital chart and confirmed by administration of the C-SSRS

3. Age > 18 years

4. Have a reliable telephone

5. Ability to speak, read, and understand English well to complete the procedures of the study

Exclusion Criteria:

1. Current psychotic symptoms severe enough to impair study participation

2. Participation in a treatment program with established efficacy in preventing suicidal behavior

3. Cognitive impairment which would interfere with adequate participation in the project (MMSE< 20).

4. Currently in state custody or pending legal action 5. Already enrolled current or previous CLASP trial

Related Conditions & MeSH terms

• Suicide

Intervention

Behavioral:
• CLASP

• SAFE

Locations

Country	Name	City	State
United States	Butler Hospital	Providence	Rhode Island

Sponsors (1)

Lead Sponsor	Collaborator
Butler Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	A composite composed of the number of participants with either a suicide attempt or death by suicide	As assessed by both the Columbia Suicide Severity Rating Scale and record review	52 weeks following discharge from hospital